Services and Procedures
The Oklahoma Breast Care Center is pleased to offer our patients access to our Breast Cancer Risk Assessment Program as a complimentary service. Designed to help women determine their individual risk of developing breast cancer, this program is administered by Stephanie Wimberley, LPN.
The program includes a consultation in which your family and personal history along with many other factors will be combined to calculate your current risk of developing breast cancer. During this consultation recommendations will be made based on your level of risk to ensure all of the screening tools are being utilized to your benefit. Genetic testing may be offered to you based on the information gathered during this assessment, it is just one more tool that we incorporate in our program that can be used to empower you as you make decisions about your breast health.
Call today to schedule an appointment: Risk Assessment Specialist - Stephanie Wimberley, LPN 405-755-2273(CARE) ext 222.
Risk Assessment Specialist
for Your Appointment
to wear skirt/slacks to allow for easy disrobing from the waist up. Avoid
use of heavy antiperspirant
and please do not wear body powder, lotion or perfume on the breast area.
If your appointment is for a diagnositc mammogram, ultrasound, biopsy, breast MRI or a bone density screening a referring doctor's order may be required. Please inquire when scheduling your appointment with either of our offices.
For patients under the age of 35; a doctor's order is required for screening mammograms.
screening mammogram is a safe, low-dose x-ray of the breast. Two views
are taken of each breast. A Diagnostic mammogram is necessary when
there is a problem and additional diagnostic views are needed. Implant
mammography requires additional diagnostic views to assure the maximum
amount of breast tissue is examined.
ImageChecker Results in Earlier Detection
Breast Care Center Offers Aurora Dedicated Breast MRI
Osteoporosis is one of the most common and yet poorly
understood diseases of middle and old age. The disease is a health threat
for an estimated 44 million Americans, or 55% of the people 50 years of
age and older. In the U.S. today, 10 million individuals are estimated
to already have the disease, of this number 80% are women.
Breast ultrasound helps the radiologist distinguish between
solid lumps and fluid filled cysts. Ultrasound is also utilized for
women with breast implants.
Ultrasound Guided Cyst Aspiration
Sometimes are referred to as a cyst aspiration. Fine needle aspiration
is a biopsy procedure performed on lumps that can be felt or identified
on mammography or ultrasound. If the area can be felt, this procedure
can be performed as the physician stabilizes the area with his hand for
the procedure. If the area cannot be felt, the procedure may be performed
using ultrasound or stereotactic guidance.
galactogram is a test in which x-ray dye is injected into a breast
duct prior to a mammogram. It is done to see if there is an abnormality
within the duct that may be causing discharge. This procedure is also
done to identify a duct with an abnormality prior to removal of it
by your surgeon.
you or your physician have discovered a "suspicious" lump
in your breast, your physician may want a portion of that lump to
be removed so it can be examined to make certain it is free of disease.
The procedure for removing a representative sample of that lump in
known as a biopsy. Published research indicates that more
than four out of five lumps which are considered suspicious enough
to require a biopsy are found to be free of malignancy when examined
by a pathologist.
When a suspicious area is found on a mammogram
but cannot be felt and requires further evaluation by a surgeon, needle
localization may be recommended. The procedure is performed under mammography
visualization by a radiologist prior to a scheduled surgical biopsy. The
radiologist marks the area to be biopsied with a needle and a wire. The
wire guides the surgeon to the abnormal area for removal during surgery.
The National Breast
Susan G. Komen Foundation
Imaging Technology, Inc.